ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,492Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 487

$449K Total Retail Price of All Prescriptions

Rank: 51 out of 487

473 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 473 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 473 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 6,429 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
LEVOTHYROXINE SODIUM 428 375 1 1
OMEPRAZOLE 392 283 2 2
LISINOPRIL 389 354 3 5
SIMVASTATIN 381 338 4 4
HYDROCODONE-ACETAMINOPHEN 324 191 S3 5 3
HYDROCHLOROTHIAZIDE 233 212 6 9
AMLODIPINE BESYLATE 230 211 7 6
ZOLPIDEM TARTRATE 213 153 8 14
METFORMIN HCL 163 133 9 8
CITALOPRAM HBR 150 94 10 12
TRAMADOL HCL 135 76 11 19
WARFARIN SODIUM 120 101 12 11
METOPROLOL SUCCINATE 120 91 12 15
METOPROLOL TARTRATE 117 101 14 17
FUROSEMIDE 110 73 15 7
SERTRALINE HCL 102 95 16 21
ATORVASTATIN CALCIUM 101 93 17 18
RANITIDINE HCL 99 69 18 39
TRAZODONE HCL 98 65 19 22
LOVASTATIN 91 90 20 30
ALLOPURINOL 87 67 21 29
AMITRIPTYLINE HCL 86 40 R 22 45
TRIAMTERENE-HCTZ 86 56 22 49
GABAPENTIN 81 40 24 13
OXYCODONE HCL-ACETAMINOPHEN 81 26 S2 24 142
LOSARTAN POTASSIUM 78 47 26 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 70 27 24
FLUOXETINE HCL 75 32 28 28
GLIPIZIDE ER 75 58 28 95
POTASSIUM CHLORIDE 74 58 30 10
TAMSULOSIN HCL 71 50 31 25
ATENOLOL 68 41 32 23
MORPHINE SULFATE ER 65 49 S2 33 54
NEXIUM 63 54 34 41
PRAVASTATIN SODIUM 55 55 35 20
ADVAIR DISKUS 54 47 36 46
NABUMETONE 53 40 37 148
PROAIR HFA 52 18 38 40
NAMENDA 50 44 39 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.